RAPT Therapeutics Inc (RAPT) — Defensive Interval Ratio
RAPT Therapeutics Inc (RAPT) has a Defensive Interval Ratio of 3259 days as of September 2025. Defensive assets of $119.41 Million (cash $-, short-term investments $119.41 Million, receivables $-) cover 3259 days of daily cash needs of $36.64K/day. See working capital position of RAPT Therapeutics Inc to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
RAPT Therapeutics Inc Defensive Interval Ratio (2020–2024)
This chart shows how RAPT Therapeutics Inc's Defensive Interval Ratio has evolved across 5 annual periods from 2020 to 2024. As of September 2025, the ratio stands at 3259 days, meaning defensive assets of $119.41 Million can fund 3259 days of operations without new revenue. See net asset quality index of RAPT Therapeutics Inc to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for RAPT Therapeutics Inc (2020–2024)
The table below presents the year-by-year Defensive Interval Ratio for RAPT Therapeutics Inc from 2020 to 2024, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see RAPT Therapeutics Inc (RAPT) market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 463 days | $61.32 Million | $132.47K/day | $- | $61.32 Million | ▼ -1399 days |
| 2023 | 1862 days | $111.38 Million | $59.82K/day | $- | $111.38 Million | ▼ -3530 days |
| 2022 | 5392 days | $210.12 Million | $38.97K/day | $- | $210.12 Million | ▼ -909 days |
| 2021 | 6301 days | $165.63 Million | $26.29K/day | $- | $165.63 Million | ▲ +3609 days |
| 2020 | 2692 days | $86.59 Million | $32.17K/day | $- | $86.59 Million | — |